Andrew P. Barbour
-
- Gastric Cancer Management and Outcomes 31
- Surgery top 1%
- Esophageal Cancer Research and Treatment 40
- Esophageal and GI Pathology 23
- Oncology top 2%
- Cutaneous Melanoma Detection and Management 21
- Pancreatic and Hepatic Oncology Research 16
- Gastroenterology top 2%
- Cancer Research top 5%
- Cancer Genomics and Diagnostics 12
-
- Melanoma and MAPK Pathways 11
-
- Nonmelanoma Skin Cancer Studies 10
- Co-authors
- B. Mark SmithersBryan BurmeisterVal GebskiJohn ZalcbergKatrin Marie SjoquistR. J. SimesJanine ThomasD. C. Gotley
- Partner nations
- AustraliaUnited StatesUnited Kingdom
In The Last Decade
Andrew P. Barbour
92 papers receiving 4.0k citations
Hit Papers
Peers
Comparison fields: 5 of 115
- Pulmonary and Respiratory Medicine 2.2k
- Surgery 2.7k
- Oncology 1.3k
- Gastroenterology 219
- Cancer Research 515
Countries citing papers authored by Andrew P. Barbour
This map shows the geographic impact of Andrew P. Barbour's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andrew P. Barbour with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andrew P. Barbour more than expected).
Fields of papers citing papers by Andrew P. Barbour
This network shows the impact of papers produced by Andrew P. Barbour. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andrew P. Barbour. The network helps show where Andrew P. Barbour may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Andrew P. Barbour, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 2 | |
| 2 | 2023 | 1 | |
| 3 | 2023 | 9 | |
| 4 | 2023 | 9 | |
| 5 | 2022 | 14 | |
| 6 | 2022 | 2 | |
| 7 | 2020 | 2 | |
| 8 | 2019 | 5 | |
| 9 | 2019 | 14 | |
| 10 | 2018 | 24 | |
| 11 | Pancreatic cancer: Is the surgeon still relevant? | 2016 | 0 |
| 12 | 2016 | 19 | |
| 13 | 2015 | 25 | |
| 14 | 2015 | 23 | |
| 15 | 2015 | 29 | |
| 16 | 2013 | 10 | |
| 17 | Management of loco-regionally recurrent melanoma | 2012 | 0 |
| 18 | 2007 | 36 | |
| 19 | 2003 | 16 | |
| 20 | Expression of the CD44v2-10 isoform confers a metastatic phenotype: importance of the heparan sulfate attachment site CD44v3. | 2003 | 55 |
About Andrew P. Barbour
Andrew P. Barbour is a scholar working on Oncology, Gastroenterology and Pulmonary and Respiratory Medicine, having authored 95 papers that have together received 4.0k indexed citations. Recurring topics across this work include Esophageal Cancer Research and Treatment (40 papers), Gastric Cancer Management and Outcomes (31 papers), Esophageal and GI Pathology (23 papers), Cutaneous Melanoma Detection and Management (21 papers), Pancreatic and Hepatic Oncology Research (16 papers), Cancer Genomics and Diagnostics (12 papers), Melanoma and MAPK Pathways (11 papers) and Nonmelanoma Skin Cancer Studies (10 papers). The work is most often cited by research in Pulmonary and Respiratory Medicine (2.2k citations), Surgery (2.7k citations) and Oncology (1.3k citations). Andrew P. Barbour has collaborated with scholars based in Australia, United States and United Kingdom. Frequent co-authors include B. Mark Smithers, Bryan Burmeister, Val Gebski, John Zalcberg, Katrin Marie Sjoquist, R. J. Simes, Janine Thomas, D. C. Gotley, Euan Walpole and Jesper B. Andersen. Their work appears in journals such as Journal of Clinical Oncology, Gastroenterology and Hepatology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.